Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 10:14 am Purchase |
2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO |
CVI Investments, Inc. | 200,000 6.200% |
200,000 (New Position) |
Filing History |
| 2025-03-18 6:39 pm Purchase |
2025-02-10 | 13G | Innoviz Technologies Ltd. INVZ |
CVI Investments, Inc. | 20,397,926 9.900% |
6,009,437 (+41.77%) |
Filing History |
| 2025-02-21 10:33 am Purchase |
2025-02-18 | 13G | ReShape Lifesciences Inc. RSLS |
CVI Investments, Inc. | 344,626 9.900% |
344,626 (New Position) |
Filing History |
| 2025-02-18 11:04 am Purchase |
2025-02-10 | 13G | Innoviz Technologies Ltd. INVZ |
CVI Investments, Inc. | 14,388,489 7.300% |
14,388,489 (New Position) |
Filing History |
| 2025-02-10 11:07 am Purchase |
2025-02-03 | 13G | Annovis Bio, Inc. ANVS |
CVI Investments, Inc. | 1,000,000 5.100% |
1,000,000 (New Position) |
Filing History |
| 2025-02-07 4:10 pm Sale |
2024-12-31 | 13G | Theriva Biologics, Inc. TOVX |
CVI Investments, Inc. | 146,136 4.900% |
-86,101 (-37.07%) |
Filing History |
| 2025-02-07 4:10 pm Sale |
2024-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
CVI Investments, Inc. | 2,446,376 4.900% |
-886,956 (-26.61%) |
Filing History |
| 2025-02-07 4:10 pm Sale |
2024-12-31 | 13G | Rigetti Computing, Inc. RGTI |
CVI Investments, Inc. | 0 0.000% |
-25,000,000 (Position Closed) |
Filing History |
| 2025-02-07 4:10 pm Unchanged |
2024-12-31 | 13G | PSQ Holdings, Inc. PSQH |
CVI Investments, Inc. | 1,285,410 3.300% |
0 (Unchanged) |
Filing History |
| 2025-02-07 4:09 pm Sale |
2024-12-31 | 13G | PSQ Holdings, Inc. PSQH |
CVI Investments, Inc. | 1,285,410 3.300% |
-1,724,590 (-57.30%) |
Filing History |
| 2025-02-07 4:09 pm Sale |
2024-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
CVI Investments, Inc. | 90,988 4.900% |
-18,310 (-16.75%) |
Filing History |
| 2025-02-07 4:09 pm Sale |
2024-12-31 | 13G | Snow Lake Resources Ltd. LITM |
CVI Investments, Inc. | 0 0.000% |
-5,000,000 (Position Closed) |
Filing History |
| 2025-02-07 4:09 pm Sale |
2024-12-31 | 13G | Gaxos.ai Inc. GXAI |
CVI Investments, Inc. | 363,625 4.900% |
-143,622 (-28.31%) |
Filing History |
| 2025-02-07 4:09 pm Sale |
2024-12-31 | 13G | Candel Therapeutics, Inc. CADL |
CVI Investments, Inc. | 0 0.000% |
-2,350,000 (Position Closed) |
Filing History |
| 2025-02-07 4:09 pm Sale |
2024-12-31 | 13G | Atossa Therapeutics, Inc. ATOS |
CVI Investments, Inc. | 5,662,500 4.300% |
-2,100,000 (-27.05%) |
Filing History |
| 2025-02-07 4:09 pm Sale |
2024-12-31 | 13G | Autonomix Medical, Inc. Common Stock AMIX |
CVI Investments, Inc. | 116,087 4.900% |
-77,885 (-40.15%) |
Filing History |
| 2025-02-05 3:00 pm Purchase |
2025-01-29 | 13G | FG Merger Corp. FGMCU |
CVI Investments, Inc. | 790,000 7.700% |
790,000 (New Position) |
Filing History |
| 2025-01-30 09:57 am Purchase |
2025-01-23 | 13G | Iconix Brand Group, Inc. ICON |
CVI Investments, Inc. | 18,350 6.900% |
18,350 (New Position) |
Filing History |
| 2025-01-23 12:19 pm Purchase |
2025-01-15 | 13G | Silexion Therapeutics LTD SLXN |
CVI Investments, Inc. | 339,000 8.500% |
339,000 (New Position) |
Filing History |
| 2025-01-13 10:47 am Purchase |
2025-01-06 | 13G | Microbot Medical Inc. MBOT |
CVI Investments, Inc. | 1,257,143 6.100% |
1,257,143 (New Position) |
Filing History |